Illumina, Inc. (ILMN)

USD 77.88

(1.79%)

Operating Income Summary of Illumina, Inc.

  • Illumina, Inc.'s latest annual operating income in 2023 was -1.06 Billion USD , up 98.32% from previous year.
  • Illumina, Inc.'s latest quarterly operating income in 2024 Q1 was -59 Million USD , down -3.51% from previous quarter.
  • Illumina, Inc. reported an annual operating income of -4.17 Billion USD in 2022, down -3297.56% from previous year.
  • Illumina, Inc. reported an annual operating income of -123 Million USD in 2021, down -121.21% from previous year.
  • Illumina, Inc. reported a quarterly operating income of -59 Million USD for 2024 Q1, down -3.51% from previous quarter.
  • Illumina, Inc. reported a quarterly operating income of 484 Million USD for 2024 Q2, up 920.34% from previous quarter.

Annual Operating Income Chart of Illumina, Inc. (2023 - 1999)

Historical Annual Operating Income of Illumina, Inc. (2023 - 1999)

Year Operating Income Operating Income Growth
2023 -1.06 Billion USD 98.32%
2022 -4.17 Billion USD -3297.56%
2021 -123 Million USD -121.21%
2020 580 Million USD -41.12%
2019 985 Million USD 11.55%
2018 883 Million USD 45.71%
2017 606 Million USD 3.23%
2016 587.03 Million USD -4.21%
2015 612.84 Million USD 19.07%
2014 514.71 Million USD 283.81%
2013 134.1 Million USD -33.2%
2012 200.75 Million USD 0.65%
2011 199.46 Million USD -5.76%
2010 211.65 Million USD 68.52%
2009 125.59 Million USD 56.1%
2008 80.45 Million USD 126.71%
2007 -301.21 Million USD -896.6%
2006 37.81 Million USD 276.3%
2005 -21.44 Million USD -289.03%
2004 -5.51 Million USD 79.29%
2003 -26.62 Million USD 36.39%
2002 -41.85 Million USD -38.05%
2001 -30.31 Million USD -30.49%
2000 -23.23 Million USD -292.59%
1999 -5.91 Million USD 0.0%

Peer Operating Income Comparison of Illumina, Inc.

Name Operating Income Operating Income Difference
Aclaris Therapeutics, Inc. -97.35 Million USD -998.021%
Applied DNA Sciences, Inc. -10.95 Million USD -9659.625%
Aspira Women's Health Inc. -18.85 Million USD -5570.486%
Biodesix, Inc. -41.34 Million USD -2485.748%
BioNexus Gene Lab Corp. -2.59 Million USD -41117.032%
bioAffinity Technologies, Inc. -7.97 Million USD -13307.368%
bioAffinity Technologies, Inc. -7.97 Million USD -13307.368%
Bionano Genomics, Inc. -215.24 Million USD -396.643%
CareDx, Inc -101.9 Million USD -949.068%
Check-Cap Ltd. -19.28 Million USD -5442.593%
Castle Biosciences, Inc. -67.97 Million USD -1472.591%
DarioHealth Corp. -56.18 Million USD -1802.508%
Exact Sciences Corporation -215.01 Million USD -397.182%
Fulgent Genetics, Inc. -72.69 Million USD -1370.528%
Guardant Health, Inc. -564.72 Million USD -89.296%
ICON Public Limited Company 956.15 Million USD 211.802%
IDEXX Laboratories, Inc. 1.09 Billion USD 197.436%
Intelligent Bio Solutions Inc. -10.28 Million USD -10295.623%
iSpecimen Inc. -11.16 Million USD -9470.835%
Standard BioTools Inc. -76.6 Million USD -1295.561%
MDxHealth SA -27.32 Million USD -3811.882%
23andMe Holding Co. -321.35 Million USD -232.653%
Medpace Holdings, Inc. 336.82 Million USD 417.375%
Myriad Genetics, Inc. -123.7 Million USD -764.188%
Mainz Biomed B.V. -26.64 Million USD -3912.058%
ENDRA Life Sciences Inc. -10.52 Million USD -10060.887%
NeoGenomics, Inc. -107.73 Million USD -892.24%
Neogen Corporation 58.66 Million USD 1922.273%
Inotiv, Inc. -81.46 Million USD -1212.301%
Natera, Inc. -446.24 Million USD -139.555%
OPKO Health, Inc. -157.02 Million USD -580.801%
Psychemedics Corporation -2.92 Million USD -36497.056%
Prenetics Global Limited -52.51 Million USD -1935.665%
Prenetics Global Limited -52.51 Million USD -1935.665%
Precipio, Inc. -7.62 Million USD -13928.871%
Personalis, Inc. -109.93 Million USD -872.384%
RadNet, Inc. 98.69 Million USD 1183.113%
Sera Prognostics, Inc. -39.82 Million USD -2584.513%
Sotera Health Company 276.69 Million USD 486.35%
Neuronetics, Inc. -30.55 Million USD -3398.724%
Star Equity Holdings, Inc. -4.34 Million USD -24497.331%
Star Equity Holdings, Inc. -4.34 Million USD -24497.331%
Trinity Biotech plc -27.04 Million USD -3852.671%
Twist Bioscience Corporation -220.83 Million USD -384.081%
Exagen Inc. -22.83 Million USD -4581.0%